These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 15260935

  • 1. Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men.
    Wagenlehner FM, Naber KG.
    Curr Urol Rep; 2004 Aug; 5(4):309-16. PubMed ID: 15260935
    [Abstract] [Full Text] [Related]

  • 2. Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men.
    Wagenlehner FM, Naber KG.
    Curr Infect Dis Rep; 2005 Jan; 7(1):9-16. PubMed ID: 15610666
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial treatment of prostatitis.
    Wagenlehner FM, Naber KG.
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):275-82. PubMed ID: 15482123
    [Abstract] [Full Text] [Related]

  • 4. The role of antibiotics in chronic bacterial prostatitis.
    Wagenlehner FM, Weidner W, Sörgel F, Naber KG.
    Int J Antimicrob Agents; 2005 Jul; 26(1):1-7. PubMed ID: 15970433
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G, Marras E, Wagenlehner FM, Magri V.
    Cochrane Database Syst Rev; 2013 Aug 12; 2013(8):CD009071. PubMed ID: 23934982
    [Abstract] [Full Text] [Related]

  • 6. Multidisciplinary approach to prostatitis.
    Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, Giuberti R, Granatieri CM, Latino MA, Larganà G, Leli C, Maierna G, Marchese V, Massa E, Matteelli A, Montanari E, Morgia G, Naber KG, Papadouli V, Perletti G, Rekleiti N, Russo GI, Sensini A, Stamatiou K, Trinchieri A, Wagenlehner FME.
    Arch Ital Urol Androl; 2019 Jan 18; 90(4):227-248. PubMed ID: 30655633
    [Abstract] [Full Text] [Related]

  • 7. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM, Naber KG.
    Clin Microbiol Infect; 2006 May 18; 12 Suppl 3():67-80. PubMed ID: 16669930
    [Abstract] [Full Text] [Related]

  • 8. [Prostatitis syndrome].
    Wagenlehner FM, Schneider H, Weidner W.
    Urologe A; 2007 Feb 18; 46(2):W185-96; quiz W197. PubMed ID: 17285220
    [Abstract] [Full Text] [Related]

  • 9. Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status.
    Wagenlehner FM, Diemer T, Naber KG, Weidner W.
    Andrologia; 2008 Apr 18; 40(2):100-4. PubMed ID: 18336459
    [Abstract] [Full Text] [Related]

  • 10. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome.
    Schaeffer AJ.
    N Engl J Med; 2006 Oct 19; 355(16):1690-8. PubMed ID: 17050893
    [No Abstract] [Full Text] [Related]

  • 11. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS, Parikh A.
    Am J Geriatr Pharmacother; 2011 Feb 19; 9(1):37-48. PubMed ID: 21459307
    [Abstract] [Full Text] [Related]

  • 12. Bacterial persistence in the prostate after antibiotic treatment of chronic bacterial prostatitis in men with spinal cord injury.
    Krebs J, Bartel P, Pannek J.
    Urology; 2014 Mar 19; 83(3):515-20. PubMed ID: 24581511
    [Abstract] [Full Text] [Related]

  • 13. Bacterial prostatitis.
    Wagenlehner FM, Pilatz A, Bschleipfer T, Diemer T, Linn T, Meinhardt A, Schagdarsurengin U, Dansranjavin T, Schuppe HC, Weidner W.
    World J Urol; 2013 Aug 19; 31(4):711-6. PubMed ID: 23519458
    [Abstract] [Full Text] [Related]

  • 14. Current concepts in the treatment of urinary tract infections and prostatitis.
    Childs SJ.
    Am J Med; 1991 Dec 30; 91(6A):120S-123S. PubMed ID: 1767801
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial therapy for bacterial and nonbacterial prostatitis.
    Fowler JE.
    Urology; 2002 Dec 30; 60(6 Suppl):24-6; discussion 26. PubMed ID: 12521585
    [Abstract] [Full Text] [Related]

  • 16. Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.
    Wolfson JS, Hooper DC.
    Antimicrob Agents Chemother; 1989 Oct 30; 33(10):1655-61. PubMed ID: 2686545
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacotherapeutic interventions for the treatment of bacterial prostatitis.
    Marquez-Algaba E, Burgos J, Almirante B.
    Expert Opin Pharmacother; 2022 Jun 30; 23(9):1091-1101. PubMed ID: 35574695
    [Abstract] [Full Text] [Related]

  • 18. Use of quinolones in urinary tract infections and prostatitis.
    Naber KG.
    Rev Infect Dis; 1989 Jun 30; 11 Suppl 5():S1321-37. PubMed ID: 2672257
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.
    Naber KG, Sörgel F.
    Andrologia; 2003 Oct 30; 35(5):331-5. PubMed ID: 14535866
    [Abstract] [Full Text] [Related]

  • 20. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.
    Mosharafa AA, Torky MH, El Said WM, Meshref A.
    Urology; 2011 Sep 30; 78(3):511-4. PubMed ID: 21782225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.